Navigation Links
‘2-Hour Patient Acceptance Guarantee’ Program from BioPlus Specialty Pharmacy Rolls Out to Enthusiastic Physician and Patient Response

Altamonte Springs, FL (PRWEB) June 12, 2013

The 2-Hour Patient Acceptance Guarantee program from BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading specialty pharmacies, streamlines the treatment process for both patients and providers. This program, which launched on April 1, 2013, guarantees notification to physician offices in less than two hours whether their referred patients can be admitted pending insurance qualifications or are non-admitted and triaged to another pharmacy.

“Now that our program is up and running, response from prescribing physicians and patients has been overwhelmingly positive; the benefits to both prescribers and patients was just what we hoped for when we designed this program,” shares Elvin Montanez, Pharm.D., Senior Vice President at BioPlus.

BioPlus raises the bar for the entire specialty pharmacy industry with this program. “BioPlus collapses the wait time for patients and their doctors from days down to a mere two hours. Last week, our internal tracking confirmed how we are saving time for prescribers and patients, with 98 percent of our referrals meeting our two hour guarantee for processing,” says BioPlus’ Senior Director of Admissions, Amanda Brown. “Before we started our 2-Hour program, this sort of turnaround was simply unheard of – we’re proud to be touching lives and encouraging this type of meaningful change for patients,” she adds.

BioPlus pairs this 2-Hour program with a community partnering “Pay It Forward” campaign. For every referral exceeding two hours, BioPlus makes a donation in the physician’s name to a non-profit patient foundation; a smaller donation is still made for every referral processed within the guaranteed time. The non-profit patient foundations benefiting from Pay It Forward include the Patient Access Network (PAN) Foundation, the Chronic Disease Fund, and CancerCare.

“BioPlus is a wonderful supporter of the work we do at Patient Access Network Foundation, both through patient referrals and now through the new Pay it Forward campaign,” says Korab Zuka, Vice President of External Relations & Patient Services at the PAN Foundation. “Through funds donated by the Pay it Forward campaign, PAN will help an even greater number of patients who would otherwise be unable to afford their specialty medications.”

In addition to donating to patient foundations, BioPlus connects patients, as needed, to these foundations through our Patient Foundation Assistance program. Last year, we successfully linked BioPlus patients to $5.1 million in foundation grants and co-pay assistance to help cover their high co-pays and deductibles. BioPlus staff does far more than simply provide patients with the phone numbers for these various foundations; they process the funding foundation paperwork for patients. Each patient also receives continued assistance for grant renewals to ensure uninterrupted treatment.

About BioPlus Specialty Pharmacy

BioPlus is a pharmacist-owned, URAC accredited, national specialty infusion pharmacy providing high-touch services and specialty pharmaceuticals for patients with chronic diseases such as hepatitis, bleeding disorders, immune deficiencies, neuromuscular disorders, cancer, and other conditions. Licensed in all 50 states, BioPlus is one of the nation’s largest independent specialty pharmacies. Accredited by VIPPS, Accreditation Commission for Health Care (ACHC), and the Community Health Accreditation Program (CHAP), patients can contact the Pharmacy toll free at 1-888-514-8082.

For information: or
Contact: info(at)bioplusrx(dot)com
Phone: 1-888-292-0744


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Higher-spending hospitals have fewer deaths for emergency patients
2. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
3. Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
4. Study finds doctors have exaggerated fears when starting patients on insulin
5. Diagnostic Scans Tied to Radiation Risk for Gastro Patients
6. Predictors identified for rehospitalization among post-acute stroke patients
7. Pulse pressure elevation could presage cerebrovascular disease in Alzheimers patients
8. Breast cancer patients suffer treatment-related side effects long after completing care
9. Heart failure patients with diabetes may benefit from higher glucose levels
10. Gastro Woes Often Strike Rheumatoid Arthritis Patients
11. Short Walks May Ease Fatigue in Pancreatic Cancer Patients
Post Your Comments:
(Date:12/1/2015)... PITTSBURGH, PA (PRWEB) , ... December 01, 2015 ... ... or imaging facilities, radiographic technicians must mark the film for accurate interpretation by ... keep track of. Fortunately, an inventor from Sacramento, Calif., has found a way ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... it has been selected as a finalist in this year’s Fierce Innovation Awards: ... Next IT Healthcare was recognized as a finalist in the category of Digital ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s latest white paper, ... addresses a main “pain point” for merging or aligning healthcare provider organizations—when mergers ... is signed. This quick-read guidance suggests that failing to recognize the power ...
(Date:12/1/2015)... ... 01, 2015 , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, ... , The order will be from the China Disabled Persons’ Federation, a central government ... effective solution for children and adults suffering from severe and profound hearing loss ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... companies, announced today that it has officially launched a sleek, mobile-ready and user-centric ... that his company’s new website clearly outlines the benefits that its SEO services ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  Lexicon ... today that top-line data from its TELECAST ... etiprate in treating carcinoid syndrome in cancer ... the clinical benefit observed in its pivotal ... as a companion to TELESTAR primarily to ...
(Date:12/1/2015)... 2015 North America ... with analysis and forecast of revenue. --> ... segments the concerned market with analysis and forecast of ... Report "North American Orthobiologics Market by Type (Bone Allograft, ... Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) ...
(Date:12/1/2015)... , December 1, 2015 ... the addition of the  "2016 Shigella ... Innovative Technologies, Competitive Strategies, Emerging Opportunities--US, ... Japan"  report to their offering. ... the addition of the  "2016 Shigella ...
Breaking Medicine Technology: